Frank has been active a VC investor for 25 years across the full ecosystem of health tech and life sciences.
His key reason for joining imec.xpand was the focus on ground breaking nanotechnologies through a strategic line-up with the imec research institute. The disruptive nature of the achievements in this field is now allowing breakthroughs in product and platform development with medical impact which was non-existing 10 years ago.
Making impact in the medical field through emerging tech is his ambition. An unique approach to allow for earlier diagnosis and more efficient disease treatment paradigms are prerequisites for a sustainable health care system.
Frank is an industrial engineer in chemistry/biochemistry and obtained a Master Degree as well as a PhD in Medical Sciences at the University of Leuven, Belgium.